| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |